Renal Cancer - Results from #3240

The incidence and pattern of renal cell carcinoma recurrence after robotic partial nephrectomy. October 30, 2019

Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma. October 29, 2019

Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma. October 29, 2019

Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis. October 29, 2019

Negative prognostic significance of primary cilia, CD8+ tumor infiltrating lymphocytes and PD1+ cells expression in clear cell renal cancer. October 28, 2019

Current and emerging first-line systemic therapies in metastatic clear-cell renal cell carcinoma. October 28, 2019

Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts. October 28, 2019

Pazopanib-Induced Liver Toxicity in Patients With Metastatic Renal Cell Carcinoma: Effect of UGT1A1 Polymorphism on Pazopanib Dose Reduction, Safety, and Patient Outcomes. October 25, 2019

A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma. October 25, 2019

A review of checkpoint inhibitors in the management of renal cell carcinoma. October 25, 2019

Non-contrast imaging characteristics of papillary renal cell carcinoma: implications for diagnosis and subtyping. October 24, 2019

Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy. October 24, 2019

Dual role of KRT17: development of papillary renal cell tumor and progression of conventional renal cell carcinoma. October 24, 2019

Multiregion Quantification of Extracellular Signal-regulated Kinase Activity in Renal Cell Carcinoma. October 23, 2019

Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: analysis of Japanese patients in CheckMate 214 with extended follow-up. October 23, 2019

Is multidetector CT-scan able to detect T3a renal tumor before surgery? October 22, 2019

Genetic variations in MAGE-A11 predict the risk and survival of renal cell cancer. October 22, 2019

Real-World Effectiveness and Tolerability of Pazopanib as First Targeted Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Chart Review in Latin America. October 22, 2019

The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinoma. October 21, 2019

Examining Mannitol Use in Kidney Cancer Surgery: A Cautionary Tale of Extrapolated Surgical Data. October 21, 2019

Page 163 of 457